-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Leerink Partnrs Has Negative Estimate for BMY Q2 Earnings
Bristol-Myers Squibb (NYSE:BMY – Free Report) – Equities researchers at Leerink Partnrs decreased their Q2 2025 earnings estimates for shares of Bristol-Myers Squibb in a research report issued to clients and investors on Friday, April 25th. Leerink Partnrs analyst D. Risinger now forecasts that the biopharmaceutical company will post earnings per share of $1.69 for […]
Bristol-Myers Squibb (NYSE:BMY – Free Report) – Equities researchers at Leerink Partnrs decreased their Q2 2025 earnings estimates for shares of Bristol-Myers Squibb in a research report issued to clients and investors on Friday, April 25th. Leerink Partnrs analyst D. Risinger now forecasts that the biopharmaceutical company will post earnings per share of $1.69 for […]
